Reem Abdel-Haq

Reem Abdel-Haq

Auto-generated profile, based on publicly available information

Reem Abdel-Haq

Division of Biology and Biological Engineering, California Institute of Technology

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RAReem Abdel-Haq
Reem Abdel-Haq
JSJohannes C.M. Schlachetzki
Johannes C.M. Schlachetzki
CGChristopher K. Glass
Christopher K. Glass
SMSarkis K. Mazmanian
Sarkis K. Mazmanian
Microglia, the resident immune cells in the brain, are essential for modulating neurogenesis, influencing synaptic remodeling, and regulating neuroinflammation by surveying the brain microenvironment. Microglial dysfunction has been implicated in the onset and progression of several neurodevelopmental and neurodegenerative diseases; however, the multitude of factors and signals influencing microglial activity have not been fully elucidated. Microglia not only respond to local signals within the brain but also receive input from the periphery, including the gastrointestinal (GI) tract. Recent preclinical findings suggest that the gut microbiome plays a pivotal role in regulating microglial maturation and function, and altered microbial community composition has been reported in neurological disorders with known microglial involvement in humans. Collectively, these findings suggest that bidirectional crosstalk between the gut and the brain may influence disease pathogenesis. Herein, we discuss recent studies showing a role for the gut microbiome in modulating microglial development and function in homeostatic and disease conditions and highlight possible future research to develop novel microbial treatments for disorders of the brain.

30 June 2021 in Nature
Verified
Journal Article
Closed access
PDF file
WWWei-Li Wu
Wei-Li Wu
MAMark D. Adame
Mark D. Adame
CLChia-Wei Liou
Chia-Wei Liou
JBJacob T. Barlow
Jacob T. Barlow
TLTzu-Ting Lai
Tzu-Ting Lai
SMSarkis K. Mazmanian
Sarkis K. Mazmanian

8 November 2022 in eLife
Verified
Journal Article
Open access
RAReem Abdel-Haq
Reem Abdel-Haq
JSJohannes Cm Schlachetzki
Johannes Cm Schlachetzki
JBJoseph C Boktor
Joseph C Boktor
TCThaisa M Cantu-Jungles
Thaisa M Cantu-Jungles
TTTaren Thron
Taren Thron
SMSarkis K Mazmanian
Sarkis K Mazmanian
Parkinson’s disease (PD) is a movement disorder characterized by neuroinflammation, α-synuclein pathology, and neurodegeneration. Most cases of PD are non-hereditary, suggesting a strong role for environmental factors, and it has been speculated that disease may originate in peripheral tissues such as the gastrointestinal (GI) tract before affecting the brain. The gut microbiome is altered in PD and may impact motor and GI symptoms as indicated by animal studies, although mechanisms of gut-brain interactions remain incompletely defined. Intestinal bacteria ferment dietary fibers into short-chain fatty acids, with fecal levels of these molecules differing between PD and healthy controls and in mouse models. Among other effects, dietary microbial metabolites can modulate activation of microglia, brain-resident immune cells implicated in PD. We therefore investigated whether a fiber-rich diet influences microglial function in α-synuclein overexpressing (ASO) mice, a preclinical model with PD-like symptoms and pathology. Feeding a prebiotic high-fiber diet attenuates motor deficits and reduces α-synuclein aggregation in the substantia nigra of mice. Concomitantly, the gut microbiome of ASO mice adopts a profile correlated with health upon prebiotic treatment, which also reduces microglial activation. Single-cell RNA-seq analysis of microglia from the substantia nigra and striatum uncovers increased pro-inflammatory signaling and reduced homeostatic responses in ASO mice compared to wild-type counterparts on standard diets. However, prebiotic feeding reverses pathogenic microglial states in ASO mice and promotes expansion of protective disease-associated macrophage (DAM) subsets of microglia. Notably, depletion of microglia using a CSF1R inhibitor eliminates the beneficial effects of prebiotics by restoring motor deficits to ASO mice despite feeding a prebiotic diet. These studies uncover a novel microglia-dependent interaction between diet and motor symptoms in mice, findings that may have implications for neuroinflammation and PD.

31 August 2023 in eLife
Verified
Journal Article
Open access
RAReem Abdel-Haq
Reem Abdel-Haq
JSJohannes Cm Schlachetzki
Johannes Cm Schlachetzki
JBJoseph C Boktor
Joseph C Boktor
TCThaisa M Cantu-Jungles
Thaisa M Cantu-Jungles
TTTaren Thron
Taren Thron
SMSarkis K Mazmanian
Sarkis K Mazmanian

30 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
RAReem Abdel-Haq
Reem Abdel-Haq
JSJohannes Schlachetzki
Johannes Schlachetzki
JBJoseph C. Boktor
Joseph C. Boktor
TCThaisa Cantu-Jungles
Thaisa Cantu-Jungles
TTTaren Thron
Taren Thron
SMSarkis K. Mazmanian
Sarkis K. Mazmanian
Parkinson’s disease (PD) is a movement disorder characterized by neuroinflammation, α-synuclein pathology, and neurodegeneration. Most cases of PD are non-hereditary, suggesting a strong role for environmental factors, and it has been speculated that disease may originate in peripheral tissues such as the gastrointestinal (GI) tract before affecting the brain. The gut microbiome is altered in PD and may impact motor and GI symptoms as indicated by animal studies, though mechanisms of gut-brain interactions remain incompletely defined. Intestinal bacteria ferment dietary fibers into short-chain fatty acids, with fecal levels of these molecules differing between PD and healthy controls and in mouse models. Among other effects, dietary microbial metabolites can modulate activation of microglia, brain-resident immune cells implicated in PD. We therefore investigated whether a fiber-rich diet influences microglial function in α-synuclein overexpressing (ASO) mice, a preclinical model with PD-like symptoms and pathology. Feeding a prebiotic high-fiber diet attenuates motor deficits and reduces α-synuclein aggregation in the substantia nigra of mice. Concomitantly, the gut microbiome of ASO mice adopts a profile correlated with health upon prebiotic treatment, which also reduces microglial activation. Single-cell RNA-seq analysis of microglia from the substantia nigra and striatum uncovers increased pro-inflammatory signaling and reduced homeostatic responses in ASO mice compared to wild-type counterparts on standard diets. However, prebiotic feeding reverses pathogenic microglial states in ASO mice and promotes expansion of protective disease-associated macrophage (DAM) subsets of microglia. Notably, depletion of microglia using a CSF1R inhibitor eliminates the beneficial effects of prebiotics by restoring motor deficits to ASO mice despite feeding a prebiotic diet. These studies uncover a novel microglia-dependent interaction between diet and motor symptoms in mice, findings that may have implications for neuroinflammation and PD.